Vincent Lepreux

Vincent Lepreux holds extensive experience in investment and finance, currently serving as a Board Observer at Iktos and as Investment Principal at Debiopharm Innovation Fund since September 2019, where responsibilities include identifying investment opportunities and managing a portfolio focused on digital health in oncology. Additionally, Vincent serves as a board member for several companies including Strategikon, WhiteLab Genomics, Altis Labs, and Yonalink. Previously, roles included Group Finance Director at FläktGroup, where Vincent led M&A projects and regional financial management, and Senior Manager at Eight Advisory, overseeing financial due diligence for private equity clients. Vincent began a career in financial advisory at Deloitte France & UK, contributing to numerous M&A projects. Academic credentials include a Master's degree in Corporate Finance and Financial Engineering from Université Paris Dauphine and a Bachelor's degree in Business Administration from the University of Westminster.